MEDIGENE AG Medigene AG announced the appointment of Kirsty Crame, MD as Vice President, Head of Clinical Research & Development. Dr. Crame brings more than 10 years of experience in drug development and clinical operations, focusing primarily in immuno-oncology and in cell therapy development. Most recently, she served as Director of Clinical Development at Gadeta, where she led the clinical development efforts for the first in human clinical trials in the US and EU for a TCR-T therapy.
Prior to that, Dr. Crame held the Chief Operation Officer role at DiAqua where she headed up clinical and business development of the company's lead program. Kirsty holds her medical degree from the University of Amsterdam.
